• Home
  • Works
  • Tools
  • Services
  • About Us
  • InnovaBlog
  • LinkedIn
Contact Us

Home

/

Works

Scientific dissemination

  • Development of AOPs for Proteins Triggering Celiac Disease

    Development of AOPs for Proteins Triggering Celiac Disease

    Read more: Development of AOPs for Proteins Triggering Celiac Disease
  • Literature Review on Bromine & Ochratoxin A in Feed

    Literature Review on Bromine & Ochratoxin A in Feed

    Read more: Literature Review on Bromine & Ochratoxin A in Feed
  • A non-clinical and clinical IUCLID database for 530 pharmaceuticals (part I): Methodological aspects of its development

    A non-clinical and clinical IUCLID database for 530 pharmaceuticals (part I): Methodological aspects of its development

    Read more: A non-clinical and clinical IUCLID database for 530 pharmaceuticals (part I): Methodological aspects of its development
  • GMO Risk Assessment: Focus on Open Reading Frames

    GMO Risk Assessment: Focus on Open Reading Frames

    Read more: GMO Risk Assessment: Focus on Open Reading Frames
  • Development of searchable database for pre-clinical and clinical information of approved pharmaceuticals

    Development of searchable database for pre-clinical and clinical information of approved pharmaceuticals

    Read more: Development of searchable database for pre-clinical and clinical information of approved pharmaceuticals
  • Adjuvanticity and immunogenicity of proteins in genetically modified plants

    Adjuvanticity and immunogenicity of proteins in genetically modified plants

    Read more: Adjuvanticity and immunogenicity of proteins in genetically modified plants
  • Comprehensive Literature Search and email alert for Emulsifiers, Microbiota & Health

    Comprehensive Literature Search and email alert for Emulsifiers, Microbiota & Health

    Read more: Comprehensive Literature Search and email alert for Emulsifiers, Microbiota & Health
  • INTEGRATA PROJECT: Pioneering NAD-Targeted Cancer Therapies and Training Future 

    INTEGRATA PROJECT: Pioneering NAD-Targeted Cancer Therapies and Training Future 

    Read more: INTEGRATA PROJECT: Pioneering NAD-Targeted Cancer Therapies and Training Future 

Privacy Policy

Cookie Policy

Terms&Conditions

  • LinkedIn

©2024 Innovamol Srl. VAT No: IT03616930362. Share Capital: €145,000.00 fully paid.

Made by PGALLO